Abridge vs Suki
Both hold A grades on EHR depth, and that is where the similarity ends. Abridge is the documentation reference standard: Best in KLAS for Ambient AI in 2025 and 2026, the category's largest peer reviewed study with 1,306 Kaiser Permanente clinicians in NEJM AI, and Linked Evidence tracing every sentence of a note back to the source audio. Suki is a voice first assistant where the scribe is half the product: commands order medications, navigate charts, query the patient record, and stage orders for review, across bidirectional integrations that reach past Epic to Oracle Health, MEDITECH, and Elation, with Suki Platform letting other vendors embed the capability. If your failure mode is note quality and evidence a committee will accept, start with Abridge. If your failure mode is everything around the note, the ordering, navigating, and querying that eat the visit, start with Suki, and ask for its unpublished command accuracy figures during evaluation. Neither publishes pricing.
- Evidence at enterprise scale: the largest independent peer reviewed study in the category, 1,306 clinicians at Kaiser Permanente in NEJM AI, corroborated by consecutive Best in KLAS awards, where Suki's evidence base rests on reported volume of roughly 125,000 consults a week.
- Oversight is graded stronger: Linked Evidence earns an A for sentence level verification against source audio, while Suki holds a B because the accuracy rate for command interpretation and the escalation behavior for misheard commands are not published.
- Epic depth extends past documentation: structured orders and real time prior authorization through a payer and delivery system collaboration, embedded natively across Haiku, Canto, and Hyperdrive.
- You want to operate the EHR by voice, not just document: commands order medications, navigate charts, query the patient record against the specific chart, stage orders for review, and pull schedules, which Abridge does not offer.
- EHR reach across mixed estates: deep bidirectional integrations with Epic, Oracle Health, athenahealth, MEDITECH, and Elation, plus a partnership program extending to MEDENT, Azalea Health, and WellSky, a wider spread than Abridge's Epic and athenahealth center of gravity.
- A stated retention window: audio and transcripts are deleted after 30 days by default, a specific engineering commitment rather than a vague assurance, and Suki Platform lets other healthcare software vendors embed the voice and ambient capabilities.
Side-by-Side
| Axis | A Abridge |
S Suki |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | — | — |
| Clinical and Operational Evidence | — | |
| AI Safety and PHI Stewardship | — | |
| HIPAA and BAA Posture | — | — |
| Security Certifications and Trust Center | — | — |
| FDA and Regulatory Status | — | — |
| AI Governance and Bias Disclosure | — | — |
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | — | — |
| Commercial Transparency | ||
| Setting and Specialty Coverage | — |
Volume figures for both vendors are vendor published, including Suki's roughly 125,000 consults a week and Abridge's 250 plus health systems; Abridge's evidence grade reflects the scale and venue of the Kaiser Permanente study rather than a re verification of its findings. Suki's autonomy design is sensible, staging orders for clinician review rather than submitting them, but a misinterpreted medication order is a higher consequence failure than a flawed note and no command interpretation accuracy is published; press on this in evaluation. Suki's model training posture is not addressed in retrieved materials. Neither vendor publishes pricing. Third party estimates recorded in this index place Suki near $299 to $399 per provider per month with setup fees, the highest list estimate in the lane, and Abridge near $2,500 per clinician per year; all are unconfirmed.